Effect of bone marrow-derived mononuclear cell treatment, early or late after acute myocardial infarction

Circulation Research

Volumn 119, Issue 3, 2016, Pages 481-490

  Sürder, Daniel ^a,b   Manka, Robert ^a,c   Moccetti, Tiziano ^b   Lo Cicero, Viviana ^b   Emmert, Maximilian Y ^a   Klersy, Catherine ^d   Soncin, Sabrina ^b   Turchetto, Lucia ^b   Radrizzani, Marina ^b   Zuber, Michel ^a,e   Windecker, Stephan ^f   Moschovitis, Aris ^f   Bühler, Ines ^a   Kozerke, Sebastian ^c   Erne, Paul ^a,e   Lüscher, Thomas F ^a   Corti, Roberto ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b DIVISION OF CARDIOLOGY   (Switzerland)

^c ETH ZURICH   (Switzerland)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e LUZERNER KANTONSSPITAL   (Switzerland)

^f UNIVERSITY OF BERN   (Switzerland)

Author keywords

bone marrow; cell transplantation; magnetic resonance imaging; myocardial infarction; stem cell

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ACUTE HEART INFARCTION; ARTICLE; BONE MARROW DERIVED MONONUCLEAR CELL; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE VOLUME; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; BONE MARROW TRANSPLANTATION; CINE MAGNETIC RESONANCE IMAGING; CLINICAL TRIAL; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; MALE; MONONUCLEAR CELL; MYOCARDIAL INFARCTION; PROCEDURES; SWITZERLAND; TIME FACTOR; TRANSPLANTATION; TRENDS;

BONE MARROW TRANSPLANTATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOCYTES, MONONUCLEAR; MAGNETIC RESONANCE IMAGING, CINE; MALE; MYOCARDIAL INFARCTION; SWITZERLAND; TIME FACTORS; TREATMENT OUTCOME;

EID: 84978043708     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.308639     Document Type: Article

References (33)

1. Delewi R, Hirsch A, Tijssen JG, Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-Analysis. Eur Heart J 2014 35 989 998. doi: 10.1093/eurheartj/eht372
2. Jeevanantham V, Butler M, Saad A, Abdel-Latif A, Zuba-Surma EK, Dawn B, Adult bone marrow cell therapy improves survival and induces long-Term improvement in cardiac parameters: a systematic review and meta-Analysis. Circulation 2012 126 551 568. doi: 10.1161/CIRCULATIONAHA.111.086074
3. Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A, Watt SM, Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 2008 29 1807 1818. doi: 10.1093/eurheartj/ehn220
4. Clifford DM, Fisher SA, Brunskill SJ, Doree C, Mathur A, Watt S, Martin-Rendon E, Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev 2012 2 CD006536
5. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, Zuba-Surma EK, Al-Mallah M, Dawn B, Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-Analysis. Arch Intern Med 2007 167 989 997. doi: 10.1001/archinte.167.10.989
6. Afzal MR, Samanta A, Shah ZI, Jeevanantham V, Abdel-Latif A, Zuba-Surma EK, Dawn B, Adult bone marrow cell therapy for ischemic heart disease: evidence and insights from Randomized Controlled Trials. Circ Res 2015 117 558 575. doi: 10.1161/CIRCRESAHA.114.304792
7. Gyöngyösi M, Wojakowski W, Lemarchand P, ACCRUE Investigators Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data. Circ Res 2015 116 1346 1360. doi: 10.1161/CIRCRESAHA.116.304346
8. Hirsch A, Nijveldt R, van der Vleuten PA, Tijssen JG, van der Giessen WJ, Tio RA, Waltenberger J, ten Berg JM, Doevendans PA, Aengevaeren WR, Zwaginga JJ, Biemond BJ, van Rossum AC, Piek JJ, Zijlstra F, HEBE Investigators Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial. Eur Heart J 2011 32 1736 1747. doi: 10.1093/eurheartj/ehq449
9. Huikuri HV, Kervinen K, Niemelä M, Ylitalo K, Säily M, Koistinen P, Savolainen ER, Ukkonen H, Pietilä M, Airaksinen JK, Knuuti J, Mäkikallio TH, FINCELL Investigators Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. Eur Heart J 2008 29 2723 2732. doi: 10.1093/eurheartj/ehn436
10. Janssens S, Dubois C, Bogaert J, Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006 367 113 121. doi: 10.1016/S0140-6736(05)67861-0
11. Lunde K, Solheim S, Aakhus S, Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006 355 1199 1209. doi: 10.1056/NEJMoa055706
12. Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Hölschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM, REPAIR-AMI Investigators Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006 355 1210 1221. doi: 10.1056/NEJMoa060186
13. Sürder D, Manka R, Lo Cicero V, Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function. Circulation 2013 127 1968 1979. doi: 10.1161/CIRCULATIONAHA.112.001035
14. Tendera M, Wojakowski W, Ruzyłło W, Chojnowska L, Kepka C, Tracz W, Musiałek P, Piwowarska W, Nessler J, Buszman P, Grajek S, Breborowicz P, Majka M, Ratajczak MZ, REGENT Investigators Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J 2009 30 1313 1321. doi: 10.1093/eurheartj/ehp073
15. Traverse JH, Henry TD, Ellis SG, Cardiovascular Cell Therapy ResearchNetwork Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. JAMA 2011 306 2110 2119. doi: 10.1001/jama.2011.1670
16. Traverse JH, Henry TD, Pepine CJ, Cardiovascular Cell Therapy Research Network (CCTRN) Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. JAMA 2012 308 2380 2389. doi: 10.1001/jama.2012.28726
17. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H, Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004 364 141 148. doi: 10.1016/S0140-6736(04)16626-9
18. Sürder D, Schwitter J, Moccetti T, Cell-based therapy for myocardial repair in patients with acute myocardial infarction: rationale and study design of the SWiss multicenter Intracoronary Stem cells Study in Acute Myocardial Infarction (SWISS-AMI). Am Heart J 2010 160 58 64. doi: 10.1016/j.ahj.2010.03.039
19. Assmus B, Leistner DM, Schächinger V, REPAIR-AMI Study Group Long-Term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival. Eur Heart J 2014 35 1275 1283. doi: 10.1093/eurheartj/ehu062
20. Assmus B, Rolf A, Erbs S, REPAIR-AMI Investigators Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circ Heart Fail 2010 3 89 96. doi: 10.1161/CIRCHEARTFAILURE.108.843243
21. Moccetti T, Sürder D, Klersy C, Vassalli G, Crljenica C, Rossi MG, Pasotti E, Soldati G, Sustained improvement in left ventricular function after bone marrow derived cell therapy in patients with acute ST elevation myocardial infarction. A 5-year follow-up from the Stem Cell Transplantation in Ischaemic Myocardium Study. Swiss Med Wkly 2012 142 w13632. doi: 10.4414/smw.2012.13632
22. Meyer GP, Wollert KC, Lotz J, Pirr J, Rager U, Lippolt P, Hahn A, Fichtner S, Schaefer A, Arseniev L, Ganser A, Drexler H, Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. Eur Heart J 2009 30 2978 2984. doi: 10.1093/eurheartj/ehp374
23. Traverse JH, Henry TD, Pepine CJ, Willerson JT, Ellis SG, One-year follow-up of intracoronary stem cell delivery on left ventricular function following ST-elevation myocardial infarction. JAMA 2014 311 301 302. doi: 10.1001/jama.2013.282674
24. O'Gara PT, Kushner FG, Ascheim DD, CF/AHA Task Force 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013 127 529 555. doi: 10.1161/CIR.0b013e3182742c84
25. Sürder D, Gisler V, Corti R, Moccetti T, Klersy C, Zuber M, Windecker S, Moschovitis A, Kozerke S, Lüscher TF, Erne P, Manka R, Thrombus formation in the left ventricle after large myocardial infarction-Assessment with cardiac magnetic resonance imaging. Swiss Med Wkly 2015 145 w14122. doi: 10.4414/smw.2015.14122
26. Goetti R, Kozerke S, Donati OF, Sürder D, Stolzmann P, Kaufmann PA, Lüscher TF, Corti R, Manka R, Acute, subacute, and chronic myocardial infarction: quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging. Radiology 2011 259 704 711. doi: 10.1148/radiol.11102216
27. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM, The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000 343 1445 1453. doi: 10.1056/NEJM200011163432003
28. Knuesel PR, Nanz D, Wyss C, Buechi M, Kaufmann PA, von Schulthess GK, Lüscher TF, Schwitter J, Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance: relation to functional outcome after revascularization. Circulation 2003 108 1095 1100. doi: 10.1161/01.CIR.0000085993.93936.BA
29. White IR, Royston P, Wood AM, Multiple imputation using chained equations: Issues and guidance for practice. Stat Med 2011 30 377 399. doi: 10.1002/sim.4067
30. Barron E, Lara J, White M, Mathers JC, Blood-borne biomarkers of mortality risk: systematic review of cohort studies. PLoS One 2015 10 e0127550. doi: 10.1371/journal.pone.0127550
31. Haaf P, Balmelli C, Reichlin T, N-Terminal pro B-Type natriuretic peptide in the early evaluation of suspected acute myocardial infarction. Am J Med 2011 124 731 739. doi: 10.1016/j.amjmed.2011.02.035
32. Paneni F, Costantino S, Kränkel N, Cosentino F, Lüscher TF, Reprogramming ageing and longevity genes restores paracrine angiogenic properties of early outgrowth cells. Eur Heart J 2016 37 1733 1737. doi: http://dx.doi.org/10.1093/eurheartj/ehw073
33. Jakob P, Doerries C, Briand S, Loss of angiomiR-126 and 130a in angiogenic early outgrowth cells from patients with chronic heart failure: role for impaired in vivo neovascularization and cardiac repair capacity. Circulation 2012 126 2962 2975. doi: 10.1161/CIRCULATIONAHA.112.093906